6-9 November 2011

Come and see us on stand no. 67

BCI researchers will be presenting a variety of sessions, presentations and posters, please see below for details.

Monday 7 November 2011

Parallel Sessions

• The 'Centre of the Cell' and its role in science education
  Frances Balkwill

Poster Session A

• A28 - Acquired paclitaxel resistance increases oncolytic adenovirus delivery and efficacy in ovarian cancer
  Carin K. Ingemarsdotter, Sarah K. Baird, Laura A. Tookman, Katrina J. Pirlo, Iain A. McNeish
• A172 - The adenoviral assembly protein L4-100k is a critical effector of adenoviral induced cell death in murine cancer cells
  Kyra Archibald, Anna Mary Young, Alexander Pool, Katrina Pirlo, Iain McNeish
• A214 - Stromal entrapment of immune cells in pancreatic ductal adenocarcinoma
  Abasi Ene-Obong, Andrew J. Clear, Alan G. Ramsay, Adam Woolf, John G. Gribben, Hemant M. Kocher
• A215 - Heterogeneity in triple negative breast cancers: C-met identifies aggressive breast cancer in British-Black women
  Rebecca Bowen, C Ho-Yen, R Vaziri, J Hulit, D Ryan, M Ornstein, Y White, C Choy, S Kermorgant, JL Jones
• RH1 - The different genetic alterations between Western and Chinese prostate cancers indicate the aetiology
  Xueying Mao, Nuria Coll Bastus, Lara Boyd, Yongwei Yu, Guoping Ren, Lius Beltran, Tim Oliver, Bryan Young, Daniel Berney, Yong-Jie Lu
• LB81 - Recurrent chromosomal rearrangement in prostate cancer at the ATRNL1 gene locus on 10q26
  Elzbieta Stankiewicz, Xueying Mao, Lara Boyd, Tracy Chaplin, Sakunthala Kudahetti, Liyan Xue, Dongmei Lin, Bryan Young, Daniel Berney, Yong-Jie Lu

Tuesday 8 November 2011

Proffered Paper Sessions - Cancer cell and model systems II

• Role of autocrine TNF in pancreatic tumour progression
  Maud Bossard, Eleni Maniati, Natalie Cook, David Tuveson, Frances Balkwill, Thorsten Hagemann
  
  

Parallel Sessions - Phosphoinositol signalling and cancer

• Introduction: Phosphoinositol signalling and cancer
  Bart Vanhaesebroeck
• Direct and indirect actions of PI 3-kinase in cancer
  Bart Vanhaesebroeck
  
  

Symposia - The diagnostic and therapeutic potential of the tumour microenvironment

• Introduction: The diagnostic and therapeutic potential of the tumour microenvironment
  Thorsten Hagemann
  
  

Poster Session B

• B168 - Phosphoproteomics analysis of leukaemia cells identifies novel activation markers of kinases targeted by MEK, PI3K and JAK inhibitors and suggests a mechanism of resistance to such compounds
  Pedro Cutillas
• B190 - Role of autocrine TNF in pancreatic tumour progression
  Maud Bossard, Eleni Maniati, Natalie Cook, David Tuveson, Frances Balkwill, Thorsten Hagemann
• B193 - RhoC interacts with integrin a5ß1 and enhances its trafficking in migrating carcinoma cells?
  Emilios Gemenetzidis, Ningfeng Fiona Li, Francis J Marshall, Derek Davies, Yongwei Yu, Kristopher Frese, Fieke EM Froeling, Adam K Woolf, Roger M, M Feakins, Yoshiki Naito, Christine Iacobuzio-Donahue, David A Tuveson, Ian R Hart, Hemant M Kocher
• B204 - The possibilities of HDAC inhibition as a therapeutic strategy in pancreatic cancer
  Mohammed A Ghallab, Helen C Hurst, Ian R Hart, Satya Bhattacharya, Hemant M Kocher
• B243 - Monoclonal origin of multifocal cancer and the step-wise genetic events of prostate carcinogenesis
  Xueying Mao, Lara Boyd, Liyan Xue, Dongmei Lin, Tracy Chaplin, Lius Beltran, Greg Shaw, John Hines, Tim Oliver, Daniel Berney, Bryan Young, Yong-Jie Lu 
•  B193 - RhoC interacts with integrin a5ß1 and enhances its trafficking in migrating carcinoma cells?
  Emilios Gemenetzidis, Ningfeng Fiona Li, Francis J Marshall, Derek Davies, Yongwei Yu, Kristopher Frese, Fieke EM Froeling, Adam K Woolf, Roger M ...
• LB132 - Polo-like Kinase 2 as a potential therapeutic target for MSH2 deficient cancer
  Parvati Addingadoo, Madeleine Hewish, Christopher Lord, Alan Ashworth, Sarah Martin
• LB146 - Bioinformatics portal for the Breast Cancer Campaign Tissue Bank
  Rosalind Cutts, Philip Quinlan, Andrew Green, Valerie Speirs, Louise Jones, Claude Chelala

The ESGCT and BSGT Collaborative Congress 2011 The Brighton Centre Brighton, UK 27-31 October 2011

 
Two of the BCI’s senior academics are giving oral presentations in the Cancer Gene and Virotherapy session on Saturday 29 October.

Professor Iain McNeish is presenting:
“Targeting DNA damage repair and paclitaxel resistance in ovarian cancer using oncolytic adenoviruses”  

Dr Yaohe Wang is presenting:
“Enhancement of the antitumour efficacy of E3B-deleted oncolytic adenoviruses by targeting STAT1 which interacts with viral E3 14.7 protein in macrophages’.

The Viral Gene Therapy groups of Iain McNeish, Yaohe Wang and Gunnel Hallden also have 6 poster presentations at the meeting so the BCI is well represented at this meeting.

→ Click here for the full programme

Professor Nick Lemoine BCI Director and the Editor of the Nature Specialist Journal Gene Therapy,  has made a series of video interviews with leading scientists at the meeting.